The yen for success  by Swindells, Mark
My word
The yen for success
Mark Swindells
Basic and applied research have
historically been rather uncomfortable
bedfellows, but biotechnology is one
area where progress from concept to
application can be staggeringly fast.
Less than 10 years ago researchers
were pondering how to sequence
large tracts of DNA reasonably
quickly, yet today Celera has a market
capitalization of close to $1 billion for
doing just that. Facilitating crossover
from basic to applied research is now
high on the agendas of governments
in most developed countries.
Japan is seen by many as the home
of applied research but what is less
well publicised is how its goverment
tries to ease the transition to the
applied arena. When I went to work in
Japan almost 10 years ago, I hoped to
witness this at first hand. The job I
took was at a research institute jointly
funded by MITI (Ministry of
International Trade and Industry) and
several chemical and pharmaceutical
companies. The institute was, in fact,
set up as a company that had a fixed
lifetime, an approach to funding that
was first used when Japan was playing
catch-up with the US in silicon chip
technology.
In the mid-1970s, MITI
encouraged five electronics
companies to pool their knowledge of
chip technology in a limited-lifetime
joint company, by providing around
$100 million of additional government
funding. The project began in 1976
and the results were so staggering
that by the early 1980s Japan led the
rest of the world in VLSI (very large
scale integration) chip technology.
There are now many such
research insitutes in Japan. Each
institute is set up as an independent
company with an enormous reserve
of cash to use within a 5–8 year
timespan. But even in Japan, money
doesn’t guarantee results. Materially,
the institutes are great places to work
but, as you might expect, they can be
complicated politically. Furthermore,
although I can only speak about those
institutes in the biological sciences,
none of these have produced results
anywhere near as significant as those
of the original VLSI project.
Even in Japan, money doesn’t
guarantee results
Why does this model seem not to
have lived up to its original promise?
The first problem is lack of focus. I
know of no institute since the chip
project that has been set up with such
clear objectives. The two I worked at
were involved with protein
engineering and cDNA sequencing.
Protein engineering is an enormous
field and, even after it had been split
up into five research groups the
institute lacked focus. The cDNA
technology institute had the potential
to be more directed but the research
groups spread themselves too thinly
in an effort to please all the
participating companies and the
government. (It is perhaps ironic that
a simpler high-throughput facility
dedicated solely to sequencing,
would have ultimately captured the
current mood much better.)
This lack of focus also complicates
the recruitment of personnel. If the
area to be covered is large, there are
unlikely to be enough experienced
employees in any of the participating
companies. For this reason, these
institutes also recruit promising young
Japanese researchers (particularly
those doing postdocs abroad) to be
staff scientists, and supplement this
further with a postdoc scheme. This
tends to be a recipe for disaster in
many ways, but particularly when
group leaders from the industrial
sector have less senior, yet able,
scientists from academia below them.
Interactions between group leaders
from academia and industry can also
be exciting.
Publication is another tricky
subject. Although researchers from
these institutes do publish their
work, there is a clear difference
between the urgency of the
academics — who regard publication
as their lifeblood (after the fixed life
of the institute they may well have to
move back into academia) — and the
view of those from MITI, who see
success in terms of patents obtained.
These institutes are awash with
money, yet all of it is pre-allocated
before a single researcher is recruited,
with a lot going on hardware. The
salaries of direct employees are paid
at government rates. This would be
just about acceptable if they did not
then have to work with company
personnel who are on much higher
rates. Innumerable times I was asked
why more foreigners do not come to
work in Japan. The simple answer is
that a country that is not seen as a hot
spot for career progression, and has a
cost of living second to none has to
do something to tempt researchers to
its shores. Competitive salaries and
reasonable accomodation would be a
good starting point.
I reluctantly left Japan in 1998,
having been there for seven years.
Why did I stay so long? I did not go
to Japan for career progression and
was quite happy just to find a job
there in the first instance. During my
stay I was lucky enough to progress
from being a postdoc at my first
MITI institute to being a company
employee at the second. I was able to
avoid most politics and could
concentrate on working with the
many talented researchers that I met.
Who knows how long I might have
stayed if those institutes were better
set up to fulfill their great potential.
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